FibroGen Inc FGEN:NASDAQ

RT Quote | NASDAQ | USD
Last | 10/04/22 EDT
13.77quote price arrow up+0.50 (+3.77%)
Volume
729,509
52 week range
7.81 - 16.91
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close13.77
  • 52 Week High16.91
  • 52 Week High Date02/09/22
  • 52 Week Low7.81
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap1.291B
  • Shares Out93.74M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change-2.34

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close13.77
  • 52 Week High16.91
  • 52 Week High Date02/09/22
  • 52 Week Low7.81
  • 52 Week Low Date05/09/22
  • Market Cap1.291B
  • Shares Out93.74M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change-2.34

RATIOS/PROFITABILITY

  • EPS (TTM)-2.36
  • P/E (TTM)-5.82
  • Fwd P/E (NTM)-4.61
  • EBITDA (TTM)-215.045M
  • ROE (TTM)-120.82%
  • Revenue (TTM)263.15M
  • Gross Margin (TTM)93.37%
  • Net Margin (TTM)-84.24%
  • Debt To Equity (MRQ)15.84%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On FibroGen Inc

 

Content From Our Affiliates

Profile

MORE
FibroGen, Inc. is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing a pipeline of therapeutics. It applies its capabilities in hypoxia-inducible factor (HIF) biology, 2-oxoglutarate enzymology, and connective tissue growth factor (CTGF) biology to advance medicines for the treatment of anemia, fibrotic disease, and cancer. The Company’s product Roxadustat is an oral small molecule inhibitor of HIF-prolyl hydroxylase activity...
James Schoeneck
Independent Chairman of the Board
Enrique Conterno
Chief Executive Officer, Director
Juan Graham
Chief Financial Officer
Address
409 ILLINOIS STREET
San Francisco, CA
94158
United States

Top Peers

SYMBOLLASTCHG%CHG
VCYT
Veracyte Inc
18.63+1.54+9.01%
ME
23andMe Holding Co.
3.11+0.20+6.87%
LGND
Ligand Pharmaceuticals Inc
93.86+6.83+7.85%
CPRX
Catalyst Pharmaceuticals Inc
12.75-0.39-2.97%
XNCR
Xencor Inc
26.81+0.98+3.79%